Peter Kolchinsky, 10% Owner at AN2 Therapeutics, Inc. (ANTX), bought 1,966,665 shares at $15.00 ($25.0M) on 2022-03-29, disclosed to the SEC on 2022-03-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 299,999 | $0 | 0.0% |
| 2 | $15.00 | 115,613 | $1.7M | 6.9% |
| 3 | $15.00 | 1,551,053 | $23.3M | 93.1% |
| Total | $12.71 avg | 1,966,665 | $25.0M | 100% |
| Filing → |
| VOR | SELL | 2025-10-30 | $20.7M | — | Filing → |
| CDTX | BUY | 2025-06-30 | $100.0M | — | Filing → |
| TYRA | BUY | 2025-06-06 | $23.5M | — | Filing → |